Dr. Mackrell’s extensive clinical experience will be valuable to our clients developing and evaluating medical device products used to treat cardiovascular diseases and promote wound healing.
WASHINGTON (PRWEB)
May 11, 2022
NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified vascular surgeon, has joined the company as an Expert Consultant. Dr. Mackrell is a practicing surgeon with Vascular Surgery Associates, LLC and serves as Chief of the Division of Vascular Surgery and Co-Director of the Non-invasive Vascular Lab at the Greater Baltimore Medical Center and Sinai Hospital of Baltimore. He is an expert in peripheral arterial disease, venous disease, general surgery, trauma, wound healing, and cardiovascular percutaneous interventions and formerly served as Co-Director of the wound care center at the Greater Baltimore Medical Center. He is a member of the Society for Vascular Surgery and serves on advisory committees at the Greater Baltimore Medical Center and Cardiovascular Institute Council of the Sinai Hospital of Baltimore.
According to Deb Koeneman, Manager of NDA Partners’ medical device practice, “Dr. Mackrell’s extensive clinical experience will be valuable to our clients developing and evaluating medical device products used to treat cardiovascular diseases and promote wound healing. We are pleased to welcome him to NDA Partners.”
Dr. Peter Mackrell earned his medical degree from Georgetown University School of Medicine and bachelor’s degree in economics from Princeton University. He completed his residency at New York Presbyterian Hospital, Cornell University Medical Center and fellowship in peripheral and endovascular surgery at Greenville Memorial Hospital in Greenville, South Carolina.
About NDA Partners
NDA Partners, a ProPharma Group company, is a life sciences management consulting and contract development organization focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, product development program design and management, expert consulting, functional teams, project-based solutions, and clinical trial design and management.
Contact
Eric Fish, General Manager
Office: 540-738-2550
FishEric@ndapartners.com
Share article on social media or email: